682 related articles for article (PubMed ID: 25724184)
1. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
[TBL] [Abstract][Full Text] [Related]
2. Influence of the CYP1A1 T3801C Polymorphism on Tobacco and Alcohol-Associated Head and Neck Cancer Susceptibility in Northeast India.
Singh SA; Choudhury JH; Kapfo W; Kundu S; Dhar B; Laskar S; Das R; Kumar M; Ghosh SK
Asian Pac J Cancer Prev; 2015; 16(16):6953-61. PubMed ID: 26514474
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
Singh SA; Ghosh SK
Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
[TBL] [Abstract][Full Text] [Related]
4. Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population.
Choudhury JH; Ghosh SK
J Oral Pathol Med; 2015 Aug; 44(7):495-501. PubMed ID: 25167831
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of smoking and polymorphisms in tobacco carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and neck cancer risk in North Indians.
Sharma R; Ahuja M; Panda NK; Khullar M
DNA Cell Biol; 2010 Aug; 29(8):441-8. PubMed ID: 20491576
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.
Peddireddy V; Badabagni SP; Gundimeda SD; Mamidipudi V; Penagaluru PR; Mundluru HP
Eur J Med Res; 2016 Apr; 21():17. PubMed ID: 27090234
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
[TBL] [Abstract][Full Text] [Related]
8. Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.
Sam SS; Thomas V; Reddy KS; Surianarayanan G; Chandrasekaran A
J Cancer Res Clin Oncol; 2010 Jun; 136(6):945-51. PubMed ID: 20012094
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.
Lourenço GJ; Silva EF; Rinck-Junior JA; Chone CT; Lima CS
Tumour Biol; 2011 Dec; 32(6):1209-15. PubMed ID: 21870186
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
Hidaka A; Sasazuki S; Matsuo K; Ito H; Charvat H; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Tsugane S;
Int J Cancer; 2016 Aug; 139(4):759-68. PubMed ID: 27062139
[TBL] [Abstract][Full Text] [Related]
14. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.
Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K
Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
[TBL] [Abstract][Full Text] [Related]
17. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
Olshan AF; Weissler MC; Watson MA; Bell DA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India.
Talukdar FR; Ghosh SK; Laskar RS; Mondal R
PLoS One; 2013; 8(4):e60996. PubMed ID: 23596512
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population.
Yadav DS; Devi TR; Ihsan R; Mishra AK; Kaushal M; Chauhan PS; Bagadi SA; Sharma J; Zamoawia E; Verma Y; Nandkumar A; Saxena S; Kapur S
Genet Test Mol Biomarkers; 2010 Oct; 14(5):715-23. PubMed ID: 20854097
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
